Granules is among the most consistently innovative companies in the generic pharmaceutical industry. It is known for building upon the concept of Pharmaceutical Formulations Intermediates (PFI) and producing them at a large scale. This allows the firm to provide premixed ingredients to pharma companies around the world at high speed efficiency and low cost, thereby ultimately making medications less expensive and more readily available.
In this case study, we look at the factors that have led to Granules’ successes. We also explore the ambitions and context that have led its leaders to position themselves for rapid global expansion, after 30 years of steady growth.